Stephanie Trunk’s Insights

333 total results. Page 22 of 28.

Health Care Counsel Blog
HOPPS Proposed Rule Recommends Big Changes to 340B Program
Health Care Counsel Blog
FDA Issues Draft Guidance For Product Identifier Requirements
Alerts
Sweeping Nevada Law to Impact Manufacturers, PBMs, Pharma Sales Representatives, and Nonprofit Organizations
Health Care Counsel Blog
Pharma Industry Take Note: Maryland Passed Price-Gouging Prohibition
Health Care Counsel Blog
Reminder to Generic Manufacturers: Q1 2017 Unit Rebate Amounts Billed by State Medicaid Programs Will NOT Include Additional Discounts
Health Care Counsel Blog
Not Just for Health Care Providers Anymore: Health IT Vendor Pays $155 Million to Settle False Claims Act Case
Health Care Counsel Blog
HRSA Delays Effective Date of 340B Final Rule...Again
Health Care Counsel Blog
Implementation and Enforcement of 340B Final Rule Delayed
Alerts
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
Health Care Counsel Blog
Recent Drug Company Settlement Highlights Unique Theory of False Claims Act Liability: Failure to Follow Current Good Manufacturing Practices
Health Care Counsel Blog
FDA Finalizes Guidance on Assessing New Drug Abuse Potential
Health Care Counsel Blog
The Secret's Out: FDA Allows Drug and Device Manufacturers to Share HCEI Prior to Product Approval